LPR and GLD mutations ameliorate experimental allergic encephalomyelitis

Kimberly A S Abet Ko, Kathy A. Kelly, John Hunter, Russell

Research output: Contribution to journalArticle

Abstract

The autosomal recessive mutations of CD95 and CD95L, Ipr and gld , respectively, produce lymphadenopathy and are associated with spontaneous autoimmune disease, especially a renal disease with similarities to the human disease systemic lupus erythematosus. CD95 and CD95L appear to regulate autoreactive T cell expansion by causing T cell death when previously activated T cells are stimulated through their T cell receptor. CD95L expression on testes and corneal epithelia has been implicated as the molecular basis of immune privilege, serving to lyse invading CU95+ T cell effectors. In animals with the Ipr and gld mutations, either of these processes would exacerbate experimental allergic encephalomyelitîs (EAE), an animal model of the autoimmne demyelinating disease multiple sclerosis. However, initial experiments examining the effect of these mutations on EAE in C57BL/6 mice (H - 2b) indicate that they ameliorate, rather than exacerbate, the duration and severity of clinical signs of EAE. To better examine the magnitude of this effect, we introduced the mutations onto the more susceptible B10.PL (H-T) background, and have generated mice that are homozygous for H - 2", but +/+, +/-, or -/- with respect to the Ipr or gld mutation. Our results in these mice to date support the interpretation that the Ipr and gld mutations dramatically ameliorate induced EAE. We are currently delineating the mechanism by which these mutations exert their effect. Preliminary studies suggest that Ipr and gld mice are capable of producing a normal delayed type hypersensitivity (DTH) response to the purified protein derivative (PPD) of Bacillus calumttti guerin (BCG) in vivo and that MBP-specific T cell lines generated from these mice exhibit a Thl cytokine profile. The levels of TNFo and lymphotoxin, cytokines associated with the pathogenesis of EAE, in wildtype and mutant mice are also being determined, as is the expression of TGF-/3, a cytokine associated with the resolution of EAE.

Original languageEnglish (US)
JournalFASEB Journal
Volume10
Issue number6
StatePublished - 1996
Externally publishedYes

Fingerprint

T-cells
Autoimmune Experimental Encephalomyelitis
encephalitis
Fas Ligand Protein
mutation
T-lymphocytes
Mutation
T-Lymphocytes
mice
Cytokines
cytokines
Animals
Lymphotoxin-alpha
lymphotoxin
Bacilli
Cell death
T-Cell Antigen Receptor
lupus erythematosus
lymphatic diseases
Corneal Epithelium

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

LPR and GLD mutations ameliorate experimental allergic encephalomyelitis. / Abet Ko, Kimberly A S; Kelly, Kathy A.; Hunter, John; Russell.

In: FASEB Journal, Vol. 10, No. 6, 1996.

Research output: Contribution to journalArticle

Abet Ko, Kimberly A S ; Kelly, Kathy A. ; Hunter, John ; Russell. / LPR and GLD mutations ameliorate experimental allergic encephalomyelitis. In: FASEB Journal. 1996 ; Vol. 10, No. 6.
@article{85c41898f9b64f4b8e4b9ca9fedfa649,
title = "LPR and GLD mutations ameliorate experimental allergic encephalomyelitis",
abstract = "The autosomal recessive mutations of CD95 and CD95L, Ipr and gld , respectively, produce lymphadenopathy and are associated with spontaneous autoimmune disease, especially a renal disease with similarities to the human disease systemic lupus erythematosus. CD95 and CD95L appear to regulate autoreactive T cell expansion by causing T cell death when previously activated T cells are stimulated through their T cell receptor. CD95L expression on testes and corneal epithelia has been implicated as the molecular basis of immune privilege, serving to lyse invading CU95+ T cell effectors. In animals with the Ipr and gld mutations, either of these processes would exacerbate experimental allergic encephalomyelit{\^i}s (EAE), an animal model of the autoimmne demyelinating disease multiple sclerosis. However, initial experiments examining the effect of these mutations on EAE in C57BL/6 mice (H - 2b) indicate that they ameliorate, rather than exacerbate, the duration and severity of clinical signs of EAE. To better examine the magnitude of this effect, we introduced the mutations onto the more susceptible B10.PL (H-T) background, and have generated mice that are homozygous for H - 2{"}, but +/+, +/-, or -/- with respect to the Ipr or gld mutation. Our results in these mice to date support the interpretation that the Ipr and gld mutations dramatically ameliorate induced EAE. We are currently delineating the mechanism by which these mutations exert their effect. Preliminary studies suggest that Ipr and gld mice are capable of producing a normal delayed type hypersensitivity (DTH) response to the purified protein derivative (PPD) of Bacillus calumttti guerin (BCG) in vivo and that MBP-specific T cell lines generated from these mice exhibit a Thl cytokine profile. The levels of TNFo and lymphotoxin, cytokines associated with the pathogenesis of EAE, in wildtype and mutant mice are also being determined, as is the expression of TGF-/3, a cytokine associated with the resolution of EAE.",
author = "{Abet Ko}, {Kimberly A S} and Kelly, {Kathy A.} and John Hunter and Russell",
year = "1996",
language = "English (US)",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - LPR and GLD mutations ameliorate experimental allergic encephalomyelitis

AU - Abet Ko, Kimberly A S

AU - Kelly, Kathy A.

AU - Hunter, John

AU - Russell,

PY - 1996

Y1 - 1996

N2 - The autosomal recessive mutations of CD95 and CD95L, Ipr and gld , respectively, produce lymphadenopathy and are associated with spontaneous autoimmune disease, especially a renal disease with similarities to the human disease systemic lupus erythematosus. CD95 and CD95L appear to regulate autoreactive T cell expansion by causing T cell death when previously activated T cells are stimulated through their T cell receptor. CD95L expression on testes and corneal epithelia has been implicated as the molecular basis of immune privilege, serving to lyse invading CU95+ T cell effectors. In animals with the Ipr and gld mutations, either of these processes would exacerbate experimental allergic encephalomyelitîs (EAE), an animal model of the autoimmne demyelinating disease multiple sclerosis. However, initial experiments examining the effect of these mutations on EAE in C57BL/6 mice (H - 2b) indicate that they ameliorate, rather than exacerbate, the duration and severity of clinical signs of EAE. To better examine the magnitude of this effect, we introduced the mutations onto the more susceptible B10.PL (H-T) background, and have generated mice that are homozygous for H - 2", but +/+, +/-, or -/- with respect to the Ipr or gld mutation. Our results in these mice to date support the interpretation that the Ipr and gld mutations dramatically ameliorate induced EAE. We are currently delineating the mechanism by which these mutations exert their effect. Preliminary studies suggest that Ipr and gld mice are capable of producing a normal delayed type hypersensitivity (DTH) response to the purified protein derivative (PPD) of Bacillus calumttti guerin (BCG) in vivo and that MBP-specific T cell lines generated from these mice exhibit a Thl cytokine profile. The levels of TNFo and lymphotoxin, cytokines associated with the pathogenesis of EAE, in wildtype and mutant mice are also being determined, as is the expression of TGF-/3, a cytokine associated with the resolution of EAE.

AB - The autosomal recessive mutations of CD95 and CD95L, Ipr and gld , respectively, produce lymphadenopathy and are associated with spontaneous autoimmune disease, especially a renal disease with similarities to the human disease systemic lupus erythematosus. CD95 and CD95L appear to regulate autoreactive T cell expansion by causing T cell death when previously activated T cells are stimulated through their T cell receptor. CD95L expression on testes and corneal epithelia has been implicated as the molecular basis of immune privilege, serving to lyse invading CU95+ T cell effectors. In animals with the Ipr and gld mutations, either of these processes would exacerbate experimental allergic encephalomyelitîs (EAE), an animal model of the autoimmne demyelinating disease multiple sclerosis. However, initial experiments examining the effect of these mutations on EAE in C57BL/6 mice (H - 2b) indicate that they ameliorate, rather than exacerbate, the duration and severity of clinical signs of EAE. To better examine the magnitude of this effect, we introduced the mutations onto the more susceptible B10.PL (H-T) background, and have generated mice that are homozygous for H - 2", but +/+, +/-, or -/- with respect to the Ipr or gld mutation. Our results in these mice to date support the interpretation that the Ipr and gld mutations dramatically ameliorate induced EAE. We are currently delineating the mechanism by which these mutations exert their effect. Preliminary studies suggest that Ipr and gld mice are capable of producing a normal delayed type hypersensitivity (DTH) response to the purified protein derivative (PPD) of Bacillus calumttti guerin (BCG) in vivo and that MBP-specific T cell lines generated from these mice exhibit a Thl cytokine profile. The levels of TNFo and lymphotoxin, cytokines associated with the pathogenesis of EAE, in wildtype and mutant mice are also being determined, as is the expression of TGF-/3, a cytokine associated with the resolution of EAE.

UR - http://www.scopus.com/inward/record.url?scp=33749126538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749126538&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749126538

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -